Agenus AGEN
NASDAQ AGEN
$8.31 +0.07 (+0.85%)
As of: Sep 4, 2026 · 2:23 PM EDT

Agenus (AGEN) EBT Margin (2010 - 2026)

Agenus (AGEN) posted quarterly EBT Margin of 1.08% for Q1 2026, up 11034.0% year-over-year from N/an in Q1 2025, and up 122.35% quarter-over-quarter from 4.83% in Q4 2025.

Analysis

Agenus (AGEN) EBT Margin (2010 - 2026) Analysis & Trends

Agenus' EBT Margin history runs 17 years deep, the most recent figure standing at 1.08% for Q1 2026.

  • In Q1 2026, EBT Margin rose 11034.0% year-over-year to 1.08%; the TTM figure through Mar 2026 stood at 30.93% (up 17408.0% YoY), while the FY2025 annual figure was 363.48%, up 13831.0% from the prior year.
  • EBT Margin for Q1 2026 stood at 1.08%, up from 4.83% in the prior quarter.
  • The five-year high for EBT Margin was 130.93% in Q4 2022, with the low at 271.79% in Q3 2024.
  • The 5-year median for EBT Margin is 175.17% (2024), against an average of 139.99%.
  • The sharpest annual moves came in 2022 and 2023: EBT Margin jumped 99642 bps in 2022, then tumbled 25686 bps in 2023.
  • Agenus' EBT Margin stood at 130.93% in 2022, then slumped by 196 bps to 125.93% in 2023, then slumped by 39 bps to 175.17% in 2024, then surged by 97 bps to 4.83% in 2025, then surged by 122 bps to 1.08% in 2026.
  • Business Quant data shows AGEN's EBT Margin at 1.08% in Q1 2026, 4.83% in Q4 2025, and 23.06% in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Vertex Pharmaceuticals 138.87 Bn 131.01 Bn 2.84 Bn 41.75%
2 Regeneron Pharmaceuticals 85.57 Bn 77.57 Bn 3.93 Bn 35.61%
3 Argenx Se 63.51 Bn 58.32 Bn 1.37 Bn 35.78%
4 Moderna 58.19 Bn 53.05 Bn 52.00 Mn -528.97%
5 Revolution Medicines 44.07 Bn 44.07 Bn - -
6 BeOne Medicines 39.99 Bn 34.89 Bn 1.53 Bn 18.33%
7 Alnylam Pharmaceuticals 35.38 Bn 32.07 Bn 992.69 Mn 13.77%
8 Royalty Pharma 28.42 Bn 27.58 Bn - 12.09%
9 Insmed 27.41 Bn 26.25 Bn 358.27 Mn -2.67%
10 Agenus 343.52 Mn 343.52 Mn 34.52 Mn -11.44%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -11.44%
Mar 31, 2026 1.14%
Dec 31, 2025 -4.74%
Sep 30, 2025 -58.59%
Jun 30, 2025 -116.77%
Mar 31, 2025 -108.48%
Dec 31, 2024 -173.57%
Sep 30, 2024 -267.73%
Jun 30, 2024 -263.47%
Mar 31, 2024 -222.63%
Dec 31, 2023 -57.73%
Sep 30, 2023 -267.23%
Jun 30, 2023 -289.32%
Mar 31, 2023 -309.72%
Dec 31, 2022 -264.50%
Sep 30, 2022 -251.41%
Jun 30, 2022 -278.58%
Mar 31, 2022 -195.29%
Dec 31, 2021 -348.45%
Sep 30, 2021 67.59%